Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Esophageal Neoplasms | 4 | 2023 | 1646 | 1.410 |
Why?
|
| Metformin | 2 | 2023 | 905 | 0.900 |
Why?
|
| Somatotypes | 1 | 2022 | 41 | 0.790 |
Why?
|
| Pancreatic Neoplasms | 8 | 2024 | 5359 | 0.680 |
Why?
|
| Hypercholesterolemia | 1 | 2022 | 1142 | 0.510 |
Why?
|
| Colonic Neoplasms | 2 | 2023 | 2529 | 0.470 |
Why?
|
| Tramadol | 1 | 2014 | 60 | 0.460 |
Why?
|
| Electrolytes | 1 | 2014 | 274 | 0.450 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3209 | 0.430 |
Why?
|
| Propranolol | 1 | 2014 | 489 | 0.420 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2014 | 412 | 0.400 |
Why?
|
| Weight Loss | 1 | 2024 | 2683 | 0.400 |
Why?
|
| Risk Assessment | 4 | 2023 | 23953 | 0.360 |
Why?
|
| Nicotine | 1 | 2014 | 680 | 0.340 |
Why?
|
| Population Surveillance | 1 | 2020 | 2603 | 0.330 |
Why?
|
| Sweden | 3 | 2023 | 1378 | 0.310 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 2891 | 0.280 |
Why?
|
| Smoking Cessation | 1 | 2017 | 2053 | 0.260 |
Why?
|
| Adenocarcinoma | 2 | 2024 | 6330 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5835 | 0.240 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2024 | 1725 | 0.230 |
Why?
|
| Registries | 1 | 2020 | 8216 | 0.220 |
Why?
|
| Risk Factors | 10 | 2024 | 74055 | 0.220 |
Why?
|
| ROC Curve | 3 | 2020 | 3571 | 0.220 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 4020 | 0.200 |
Why?
|
| Follow-Up Studies | 6 | 2024 | 39078 | 0.200 |
Why?
|
| Sulfonylurea Compounds | 1 | 2023 | 219 | 0.190 |
Why?
|
| Immunologic Techniques | 1 | 2021 | 213 | 0.190 |
Why?
|
| Neoplasms | 2 | 2024 | 22083 | 0.180 |
Why?
|
| Intention | 1 | 2024 | 348 | 0.180 |
Why?
|
| Hospitalization | 1 | 2020 | 10698 | 0.180 |
Why?
|
| Pandemics | 1 | 2020 | 8623 | 0.180 |
Why?
|
| Algorithms | 1 | 2020 | 14002 | 0.170 |
Why?
|
| Helicobacter pylori | 1 | 2023 | 376 | 0.170 |
Why?
|
| Helicobacter Infections | 1 | 2023 | 385 | 0.170 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 20985 | 0.160 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 11095 | 0.160 |
Why?
|
| Receptors, Progesterone | 1 | 2023 | 1128 | 0.160 |
Why?
|
| Receptors, Estrogen | 2 | 2023 | 2204 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 9176 | 0.150 |
Why?
|
| Publication Bias | 2 | 2014 | 160 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2024 | 22097 | 0.140 |
Why?
|
| Logistic Models | 2 | 2023 | 13240 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2024 | 952 | 0.130 |
Why?
|
| Humans | 24 | 2024 | 760437 | 0.130 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 302 | 0.130 |
Why?
|
| Prognosis | 4 | 2020 | 29551 | 0.130 |
Why?
|
| Leptin | 1 | 2023 | 1593 | 0.120 |
Why?
|
| Breast Feeding | 1 | 2023 | 1357 | 0.120 |
Why?
|
| Vitamins | 1 | 2023 | 1635 | 0.120 |
Why?
|
| Incidence | 3 | 2022 | 21322 | 0.120 |
Why?
|
| China | 1 | 2020 | 2339 | 0.120 |
Why?
|
| Area Under Curve | 1 | 2018 | 1633 | 0.120 |
Why?
|
| Body Composition | 1 | 2023 | 2421 | 0.110 |
Why?
|
| Hypokalemia | 1 | 2014 | 153 | 0.110 |
Why?
|
| Prostate | 1 | 2022 | 1765 | 0.110 |
Why?
|
| Prospective Studies | 6 | 2024 | 54339 | 0.110 |
Why?
|
| Hypocalcemia | 1 | 2014 | 199 | 0.110 |
Why?
|
| Body Weight | 1 | 2024 | 4614 | 0.110 |
Why?
|
| Colorectal Neoplasms | 2 | 2023 | 6894 | 0.110 |
Why?
|
| Platinum | 1 | 2014 | 220 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2023 | 6813 | 0.100 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2018 | 871 | 0.100 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 12429 | 0.100 |
Why?
|
| Hyponatremia | 1 | 2014 | 279 | 0.100 |
Why?
|
| Telomerase | 1 | 2017 | 745 | 0.100 |
Why?
|
| Endonucleases | 1 | 2014 | 369 | 0.100 |
Why?
|
| Weight Gain | 1 | 2022 | 2346 | 0.100 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 3822 | 0.100 |
Why?
|
| Magnesium | 1 | 2014 | 809 | 0.090 |
Why?
|
| Hypoglycemic Agents | 2 | 2023 | 3076 | 0.090 |
Why?
|
| Educational Status | 1 | 2018 | 2518 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 983 | 0.090 |
Why?
|
| Middle Aged | 8 | 2024 | 220382 | 0.090 |
Why?
|
| Health Personnel | 1 | 2024 | 3331 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2014 | 1415 | 0.090 |
Why?
|
| Vitamin D | 1 | 2023 | 3303 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2020 | 2689 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1183 | 0.080 |
Why?
|
| Male | 9 | 2024 | 360035 | 0.080 |
Why?
|
| Alcoholism | 1 | 2018 | 1972 | 0.070 |
Why?
|
| Female | 10 | 2024 | 391875 | 0.070 |
Why?
|
| Survival Rate | 1 | 2020 | 12698 | 0.070 |
Why?
|
| Aged | 6 | 2024 | 168840 | 0.060 |
Why?
|
| Sex Factors | 1 | 2018 | 10538 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2017 | 2016 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 3183 | 0.060 |
Why?
|
| Stomach Neoplasms | 1 | 2014 | 1428 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2022 | 12932 | 0.060 |
Why?
|
| CA-19-9 Antigen | 1 | 2024 | 106 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2023 | 41366 | 0.060 |
Why?
|
| Receptors, Adiponectin | 1 | 2023 | 81 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12653 | 0.050 |
Why?
|
| Receptors, Leptin | 1 | 2023 | 350 | 0.050 |
Why?
|
| Cachexia | 1 | 2023 | 199 | 0.050 |
Why?
|
| Age Factors | 1 | 2018 | 18379 | 0.050 |
Why?
|
| Adipokines | 1 | 2023 | 310 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8519 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2023 | 329 | 0.040 |
Why?
|
| Fructose | 1 | 2022 | 288 | 0.040 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2024 | 517 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2023 | 773 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2022 | 42209 | 0.040 |
Why?
|
| Rats | 1 | 2014 | 23712 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 10180 | 0.040 |
Why?
|
| Adiponectin | 1 | 2023 | 1113 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2023 | 1155 | 0.040 |
Why?
|
| Pancreas | 1 | 2024 | 1684 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 9598 | 0.030 |
Why?
|
| Beverages | 1 | 2022 | 821 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2024 | 80430 | 0.030 |
Why?
|
| Adult | 4 | 2024 | 220781 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 550 | 0.030 |
Why?
|
| Young Adult | 1 | 2022 | 59068 | 0.030 |
Why?
|
| Child | 1 | 2022 | 80086 | 0.030 |
Why?
|
| Adolescent | 1 | 2022 | 88196 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2018 | 0.030 |
Why?
|
| Family | 1 | 2023 | 3189 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 11070 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2023 | 3306 | 0.020 |
Why?
|
| Telomere | 1 | 2017 | 931 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2017 | 3097 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 3842 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2024 | 4383 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2017 | 2929 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 58859 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 4923 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 27060 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4903 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 15867 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 168253 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11096 | 0.010 |
Why?
|
| Infant | 1 | 2023 | 36183 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10425 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9468 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16945 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13484 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15257 | 0.010 |
Why?
|
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_